HIGH FIBROBLAST GROWTH FACTOR 23 LEVELS INCREASE RISK OF SARS-COV-2 INFECTION AND MORTALITY IN END-STAGE CHRONIC KIDNEY DISEASE ON HEMODIALYSIS: A 3-YEAR FOLLOW-UP PROSPECTIVE COHORT

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/643693515b252897727da8c65b852144.pdf

Abstract Title

First Name *

Luis

Last Name *

Toro

Co-author 1

Luis Michea lmichea@nephrochile.cl Hospital Clinico Universidad de Chile Nephrology Santiago

Co-author 2

Alfredo Parra-Lucares aparra@nephrochile.cl Hospital Clinico Universidad de Chile Cardiology Santiago

Co-author 3

Gabriel Mendez-Valdes gmendez@biomedchile.cl Facultad de Medicina Universidad de Chile Medicine Santiago

Co-author 4

Eduardo Villa evilla@biomedchile.cl Facultad de Medicina Universidad de Chile Medicine Santiago

Co-author 5

Ignacio Bravo ibravo@nephrochile.cl Facultad de Medicina Universidad de Chile Medicine Santiago

Co-author 6

Catalina Pumarino cpumarino@nephrochile.cl Facultad de Medicina Universidad de Chile Medicine Santiago

Co-author 7

Patricia Ayala payala@biomedchile.cl Hospital Clinico Universidad de Chile Medicine Santiago

Co-author 8

Maria Eugenia Sanhueza msanhueza@nephrochile.cl Hospital Clinico Universidad de Chile Nephrology Santiago

Co-author 9

Ruben Torres rtorres@nephrochile.cl Hospital Clinico Universidad de Chile Nephrology Santiago

Co-author 10

Leticia Elgueta lelgueta@nephrochile.cl Hospital Clinico Universidad de Chile Nephrology Santiago

Co-author 11

Sebastian Chavez schavez@nephrochile.cl Hospital Clinico Universidad de Chile Medicine Santiago

Co-author 12

Veronica Rojas vrojas@biomedchile.cl Hospital Clinico Universidad de Chile Medicine Santiago

Co-author 13

Miriam Alvo malvo@nephrochile.cl Hospital Clinico Universidad de Chile Nephrology Santiago

Co-author 14

Co-author 15